Dormant
CCC · CCC Intelligent Solutions Holdings Inc.
Last analysed ·
Resolved Graded and closed 2026-08-07 at medium conviction — the published kill line did not fire. Coverage continued after the close; the read below is dated 2026-09-13 and is not part of the scored record.
Current thesis
Cheap, high-margin insurtech SaaS put in play: a Morgan Stanley-run sale process plus a fresh Elliott activist stake. Shares popped ~13% to ~$6 on the 2026-07-09 Reuters report yet still sit below a plausible PE take-out. The trade is deal-odds, not the claims cycle.
Kill line
A daily close below $5.40 fills the 2026-07-10 sale-rumor gap and prices the strategic review failing; a company statement ending or denying the sale process confirms the break.
Pick status
Played out resolved published kill line did not fire How this is scored →Latest analysis and events for CCC —
As of 13 September 2026, the latest FrontierPicks analysis for CCC Intelligent Solutions Holdings Inc. (CCC): Cheap, high-margin insurtech SaaS put in play: a Morgan Stanley-run sale process plus a fresh Elliott activist stake. Shares popped ~13% to ~$6 on the 2026-07-09 Reuters report yet still sit below a plausible PE take-out. The trade is deal-odds, not the claims cycle.
Kill line: A daily close below $5.40 fills the 2026-07-10 sale-rumor gap and prices the strategic review failing; a company statement ending or denying the sale process confirms the break.
Current Thesis
CCC Intelligent Solutions’ sale thesis depends on reported bidders delivering a signed acquisition above the market’s 2026-09-11 close of $6.89; a daily close below $5.40 invalidates that case. Bloomberg’s 2026-08-18 report named Copart, GTCR and Veritas Capital as interested parties, without certainty of an agreement. That remains evidence of reported interest, rather than an executable offer. Bloomberg report republished by Claims Journal.
The material development since the 2026-08-30 note is Copart’s 2026-09-10 agreement to acquire ACV for approximately $1.9 billion in cash. The inference is that CCC’s strategic-bidder case deserves less confidence because Copart has committed capital elsewhere; the announcement does not establish that Copart withdrew from CCC discussions. A signed Copart offer for CCC would overturn that inference. Copart announcement.
As an interpretation of the dated news and price record, the narrative is maturing — the 2026-08-18 bidder report is now followed by a 2026-09-11 close of $6.89, below the report-day close of $7.14. These observations support a weaker confirmation case, but the sample is too small to establish a persistent price trend or quantify acquisition odds.
Bullish and bearish views on CCC Intelligent Solutions Holdings Inc.
The model's bull view on CCC Intelligent Solutions Holdings Inc. (CCC), in brief: Reported alternatives remain relevant. Bloomberg’s 2026-08-18 report included GTCR and Veritas Capital alongside Copart. Sponsor interest preserves a possible route to an agreement, conditional on at least one reported bidder remaining engaged; confirmed withdrawal of those… The bear view: Strategic attention has another destination. Both cases follow in full.
Bull Case
- Reported alternatives remain relevant. Bloomberg’s 2026-08-18 report included GTCR and Veritas Capital alongside Copart. Sponsor interest preserves a possible route to an agreement, conditional on at least one reported bidder remaining engaged; confirmed withdrawal of those bidders would invalidate that route. Bloomberg via Claims Journal.
- Operating results support the business. CCC’s 2026-07-30 results reported second-quarter revenue of $285.9 million, up 9.8% year over year, adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of $115.5 million, and free cash flow of $82.4 million. Those are measured operating results; they establish neither a transaction valuation nor a minimum share price.
- Guidance supplies a measurable test. On 2026-07-30, CCC guided full-year revenue to $1.158–1.164 billion and adjusted EBITDA to $485–491 million. The inference that operating performance can support bidder interest loses support if the company cuts revenue guidance below $1.158 billion.
Bear Case
- Strategic attention has another destination. Copart’s 2026-09-10 ACV agreement creates a competing acquisition commitment. Any conclusion that Copart has abandoned CCC would go beyond that announcement. Copart announcement.
- Company confirmation remains missing. Asked about reported Copart interest on 2026-08-26, CCC told Repairer Driven News that it does not comment on rumors and speculation. That response confirms neither a process nor a bidder; the evidence reviewed for this refresh contains no signed CCC agreement.
- Debt constrains the valuation argument. CCC’s 2026-07-30 earnings call stated $116 million of cash, $1.3 billion of total debt and net leverage of 2.5 times adjusted EBITDA. Those figures alone cannot establish sponsor financing capacity or a plausible acquisition premium; no current financing package is available in the cited evidence.
- Insider paperwork needs careful interpretation. Officer Brian J. Herb’s 2026-08-18 Form 144 described a proposed common-stock sale following a cash stock-option exercise. The filing is an observable supply-related disclosure, rather than evidence that the proposed transaction completed or that management expects the sale process to fail.
Setup & Price Structure
The adjusted daily series records a $6.89 close on 2026-09-11, a three-month price increase of 49.8%, and a position 29.6% below its 52-week high of $9.78. The 14-period relative strength index (RSI) was 36.5 on that date. A substantial trailing gain therefore coexists with weaker recent momentum; neither measure identifies who is participating.
The 2026-08-18 report-day close of $7.14 is a public comparison level. A daily close above $7.14 would reverse the specific observation that the shares remain below that close, but would not confirm a transaction. The existing research threshold of $5.40 remains the thesis-break level; the supplied price summary does not independently establish the geometry of the previously described July gap.
Retail-oriented coverage clustered around the 2026-07-09 sale report, including several Benzinga items dated 2026-07-10. Article clustering is observable attention, not measured retail ownership. No current moving-average value, short-interest measure or fund-flow series is available here, so the evidence does not support a crowding verdict.
Catalyst Calendar (next 30 days)
No company-confirmed transaction deadline or earnings date was verified for 2026-09-13 through 2026-10-13. The reported sale process remains unscheduled.
- 2026-09-30 — Quarter-end ownership snapshot. This is the reporting-period endpoint identified in the prior coverage, not a same-day publication of institutional holdings or a deadline for Elliott to disclose the reported involvement. It does not resolve the transaction thesis.
The earlier calendar’s 2026-09-09 Copart earnings date is superseded: Copart’s official 2026-09-01 notice scheduled results for 2026-09-10 after market close, and its results release is dated 2026-09-10. That event has elapsed and supplies no forward catalyst date. Copart scheduling notice, Copart results release.
What Would Change Our Mind
Failure of the sale-premium structure is defined by a daily close below $5.40, the research threshold retained from the 2026-08-30 note. A company announcement terminating or denying the reported process would separately break the transaction thesis. Silence after the elapsed Copart event is not equivalent to either announcement.
A signed acquisition agreement above CCC’s $6.89 reference close of 2026-09-11, announced before that price invalidation, would satisfy the published case. A lower-priced agreement would establish that a process existed without satisfying the premium thesis. Separately, a reduction below the $1.158 billion revenue-guidance floor issued on 2026-07-30 would weaken the operating argument supporting bidder interest.
Correlation Notes
CCC remains a single-name transaction situation in this refresh. The documented link to Copart is Bloomberg’s 2026-08-18 bidder report; that is an event relationship, not a measured return correlation. No synchronized return series is available to establish a stable relationship with Copart or software-sector shares. Bloomberg via Claims Journal.
The 2026-07-30 revenue and guidance figures provide company-specific operating tests. An artificial-intelligence sector rally would not, by itself, verify bidder participation, financing or an acquisition premium.
Notes
- No company confirmation of a strategic review, bidder or price. The only on-record comment, 2026-08-26, was that CCC 'doesn't comment on rumors and speculation'.
- Balance sheet as stated on the 2026-07-30 Q2 call: $116M cash, $1.3B total debt, 2.5x net leverage on adjusted EBITDA.
- Pre-2026 third-party price history and SEC filings for this issuer often appear under the former symbol CCCS.
- The business is US and China P&C insurance claims workflow software; demand tracks auto collision claims volume, not AI capex.
- Management declined to address the reported sale process, the review or Elliott on the 2026-07-30 Q2 earnings call.
Related · shared themes
APGE
Apogee Therapeutics, Inc.
Apogee Therapeutics’ $135.11-per-share cash-acquisition thesis resolved with AbbVie’s completion on 2026-09-03. The 2026-09-14 Form 15 advances administrative closure, leaving no unresolved APGE acquisition catalyst.
ATAI
AtaiBeckley Inc.
AtaiBeckley's Lilly acquisition thesis resolved with completion on 2026-09-11, ending the pending-merger case. Remaining contingent payments depend on disclosed clinical and regulatory milestones; Nasdaq suspended ATAI effective 2026-09-14.
DSGR
Distribution Solutions Group, Inc.
Distribution Solutions Group’s $35.00 cash acquisition remains a completion thesis, with the minority vote and closing settling the case. HSR clearance occurred on 2026-08-20; a daily close below $33.50 invalidates the price thesis.
ATKR
Atkore Inc.
Atkore's $95.00 cash-merger thesis now turns on the October 7 shareholder vote and remaining approvals after September 14 US antitrust clearance. Completion before a weekly close below $88 constitutes success; termination negates the case.